{"id":"W4200565889","doi":"10.1358/dot.2021.57.12.3352760","title":"Delgocitinib in atopic dermatitis","year":2021,"lang":"en","type":"review","venue":"Drugs of today","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Tacrolimus; Calcineurin; Pimecrolimus; Janus kinase; Clinical trial; Dermatology; Safety profile; Ciclosporin; Pharmacology; Quality of life (healthcare); Pharmacokinetics; Janus kinase inhibitor; Adverse effect; Immunology; Transplantation; Internal medicine; Cytokine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002325172,0.0004361402,0.0008047509,0.001501174,0.0001960132,0.0006397789,0.000382811,0.0005486604,0.00564421],"category_scores_gemma":[0.0002899446,0.0001375383,0.000493197,0.0009913298,0.0001240102,0.000480251,0.0003689233,0.0009439618,0.001606638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003086634,"about_ca_system_score_gemma":0.0004771347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007025743,"about_ca_topic_score_gemma":0.001991917,"domain_scores_codex":[0.9999083,0.00001481417,0.00001544154,0.00001671164,0.00003289621,0.0000117676],"domain_scores_gemma":[0.9999214,0.00003678375,0.00001605762,0.000001967894,0.00001579889,0.000007834647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001126667,0.00006944069,0.0001342885,0.02008023,0.0001130748,0.0002016213,0.0000333372,0.0002347061,0.001616543,0.001314602,0.01827096,0.9578185],"study_design_scores_gemma":[0.00007262922,0.0001639069,0.001259598,0.005644875,0.0003131181,0.002258009,0.00004160568,0.000136891,0.0008857088,0.0008666382,0.9883417,0.00001524403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003554823,0.997785,0.00005447897,0.0001155212,0.0000984959,0.000006775114,0.00003078646,0.000007984763,0.001545548],"genre_scores_gemma":[0.002612322,0.9958543,0.0001257898,0.0001718802,0.00008334879,0.000007531678,0.00006973092,0.000001344994,0.00107388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00564421,"threshold_uncertainty_score":0.01888174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02845163800676103,"score_gpt":0.3400481662397611,"score_spread":0.311596528233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}